-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

Benzinga·08/07/2026 20:03:19
Listen to the news
RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.